Associated tags: COCH, Quality of life, Medicine, Patient, BEAR, Hearing, Medical device, FDA, Mayo Clinic, Patent, Hearing loss
Locations: WHITE BEAR LAKE, MINNESOTA, US, NV, NEW YORK, NY
Retrieved on:
Wednesday, April 24, 2024
WHITE BEAR LAKE, Minnesota, April 24, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that David R. Wells, Chief Financial Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024.
Key Points:
- WHITE BEAR LAKE, Minnesota, April 24, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that David R. Wells, Chief Financial Officer, will present a corporate overview at the Planet MicroCap Showcase: VEGAS 2024.
- The conference is being held on April 30 – May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV.
- Mr. Wells will be available for one-on-one meetings throughout the conference.
- Investors can attend the conference and request a meeting with Mr. Wells by registering at the link below:
WHITE BEAR LAKE, Minnesota , April 03, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that Brent Lucas, Chief Executive Officer, and David R. Wells, Chief Financial Officer, will present a corporate overview at the LD Micro Invitational XIV 2024.
Key Points:
- WHITE BEAR LAKE, Minnesota , April 03, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that Brent Lucas, Chief Executive Officer, and David R. Wells, Chief Financial Officer, will present a corporate overview at the LD Micro Invitational XIV 2024.
- The conference is being held on April 8 - 9, 2024 at the Sofitel Hotel in New York City.
- Time: 2:30pm ET (Track 3 – St. Germain III)
Register below to view the presentation:
Mr. Lucas and Mr. Wells will be holding one-on-one meetings with registered investors and analysts at the conference to discuss recent events and updates on clinical trials.
- To schedule a one-on-one meeting, please contact Dean Summers at LD Micro ( [email protected] ) or CORE IR ( [email protected] ).
House,
Growth,
Congress,
Patient,
COCH,
EFS,
Classification,
Hope,
Esteem,
Business analyst,
Insurance,
Kool-Aid,
Clinical trial,
Patent,
Medicare,
Marketing,
CMS,
Hearing,
Representative WHITE BEAR LAKE, Minn., April 02, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing devices, today announced its corporate and financial results for the fourth quarter and full year ended December 31, 2023.
Key Points:
- Completed Business Combination transaction at the end of September and began trading on Nasdaq under its own ticker, COCH, the first week of October 2023.
- Early Feasibility Study (EFS) continues to meet milestones with all three implanted patients surpassing twelve-month post-activation visits remaining implanted.
- Sales and marketing expenses increased $0.8 million for the year ended December 31, 2023 compared to the same period in 2022.
- The increase is primarily due to a $2.8 million rise in professional and legal fees in 2023 related to the finalization of the Business Combination in the third quarter of 2023.
WHITE BEAR LAKE, Minnesota, March 12, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that it will participate in the 36th Annual ROTH Conference being held on March 17 – 19, 2024 at The Ritz Carlton, Laguna Niguel located in Dana Point, CA.
Key Points:
- WHITE BEAR LAKE, Minnesota, March 12, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that it will participate in the 36th Annual ROTH Conference being held on March 17 – 19, 2024 at The Ritz Carlton, Laguna Niguel located in Dana Point, CA.
- David R. Wells, Chief Financial Officer, will be holding one-on-one meetings with investors and analysts at the conference to discuss recent events and updates on clinical trials.
- Registered attendees of the conference are encouraged to request a one-on-one meeting with Mr. Wells by contacting a ROTH representative or through the conference’s on-line platform.
WHITE BEAR LAKE, Minnesota, March 04, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems, today announced the closing of up to a $10 million, five-year lending facility provided by existing investor and billionaire entrepreneur Glen Taylor. The facility is unsecured and does not provide for conversion into equity. Envoy Medical drew $5 million on the facility at its origination.
Key Points:
- Envoy Medical drew $5 million on the facility at its origination.
- “This new financing will support the launch of our upcoming US-based pivotal clinical trial for our innovative investigational fully implanted Acclaim® cochlear implant,” said Envoy Medical CEO Brent Lucas.
- Lucas continued, “Glen remains a dedicated believer in and partner to our innovative approach toward advancing the hearing health market with innovative products.
- Further, the Company believes that recently introduced Congressional legislation to re-classify fully implanted active middle ear implants properly, is long overdue.
Retrieved on:
Wednesday, February 7, 2024
Hearing,
Classification,
Legislation,
Social,
BEAR,
Kool-Aid,
PMA,
House,
Social Security,
Dental care,
Patient,
Louisiana House of Representatives,
FDA,
Senate,
Glasses,
Hearing aid,
Medicaid,
Congress,
Ear,
CMS,
Health,
Insurance,
Medicare,
Hearing loss,
Medical device WHITE BEAR LAKE, Minnesota, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems, today announced the introduction of a new bipartisan Congressional bill, titled the Hearing Device Coverage Clarification Act. The bill seeks to clarify that fully implanted active middle ear hearing devices are prosthetics and not subject to the current Medicare hearing aid coverage exclusion.
Key Points:
- The bill seeks to clarify that fully implanted active middle ear hearing devices are prosthetics and not subject to the current Medicare hearing aid coverage exclusion.
- The Center for Medicare and Medicaid Services (“CMS”) has broadly interpreted what a “hearing aid” is to include devices that are not hearing aids.
- Fully Implanted Active Middle Ear Hearing Devices are not hearing aids for a variety of reasons.
- Envoy Medical is just one of many companies that would begin to reinvest into the fully implanted active middle ear hearing device segment,” Lucas added.
WHITE BEAR LAKE, Minnesota , Feb. 05, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems, was recently featured on the well-known Medical Alley Podcast, located online at https://www.medicalalleypodcast.org/ or wherever you get your podcasts.
Key Points:
- WHITE BEAR LAKE, Minnesota , Feb. 05, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems, was recently featured on the well-known Medical Alley Podcast, located online at https://www.medicalalleypodcast.org/ or wherever you get your podcasts.
- The podcast features top healthcare CEOs, innovative entrepreneurs, and other experts in the medical community to promote the changing state of the art in healthcare.
- Medical Alley, https://medicalalley.org/ , was founded in 1984 as a way to foster advances in healthcare for all mankind.
- “I believe investors, patients, and those interested in advancements in the medical field will enjoy and benefit from the conversation I had with Frank,” said Mr. Lucas.
WHITE BEAR LAKE, Minnesota, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that it recently has been awarded three additional patents. These patents are further evidence of Envoy Medical’s determination to be an innovation leader in hearing health to benefit patients with significant hearing loss. The patents are as follows:
Key Points:
- WHITE BEAR LAKE, Minnesota, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that it recently has been awarded three additional patents.
- These patents are further evidence of Envoy Medical’s determination to be an innovation leader in hearing health to benefit patients with significant hearing loss.
- The patents are as follows:
The US Patent & Trademark Office issued Envoy Medical Corporation US Pat.
- We believe our system’s design will allow us an opportunity to separate ourselves from others and provide patients with a new hearing option.”
WHITE BEAR LAKE, Minnesota, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that it will host a fireside chat event on Thursday December 7, 2023 beginning at noon Central Time. The event will be hosted by a covering research analyst and feature interactive Q&A with Brent T. Lucas, Chief Executive Officer, and David R. Wells, Chief Financial Officer.
Key Points:
- Analyst Hosted Event to Feature Comprehensive Discussion of Envoy Medical’s Products, Interviews with Two Study Investigators and Key Opinion Leaders in Cochlear Implants
WHITE BEAR LAKE, Minnesota, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (NASDAQ: “COCH”), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that it will host a fireside chat event on Thursday December 7, 2023 beginning at noon Central Time.
- The event will be hosted by a covering research analyst and feature interactive Q&A with Brent T. Lucas, Chief Executive Officer, and David R. Wells, Chief Financial Officer.
- In addition, the Company plans to talk with a patient who has received the Esteem® fully implanted active middle ear hearing device about what it is like hearing with a fully implanted hearing device.
- The discussion will include time with one of our Esteem® patients to hear about life with a fully implanted hearing device.
Retrieved on:
Monday, November 20, 2023
Quality of life,
Accounting,
Food,
Classification,
FDA,
Research and development,
Sensorineural hearing loss,
Surgeon,
Kool-Aid,
Research,
COCH,
BEAR,
Medicine,
Patent,
IDE,
Mayo Clinic,
Medicare,
IP,
Hearing aid,
Medicaid,
Patient,
Audiology,
Journal,
Development,
Clinical professor,
Hearing,
Envoy,
Medical device WHITE BEAR LAKE, Minn., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Envoy Medical, Inc. (“Envoy Medical”) (NASDAQ: COCH), a hearing health company, today is providing a business update and its financial results for the quarter ended September 30, 2023. The Company will host a virtual fireside chat event on December 7, which will cover a range of topics, including introductions to the technology, financial and clinical aspects of the business, as well as potential participation from cochlear implant key opinion leaders.
Key Points:
- WHITE BEAR LAKE, Minn., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Envoy Medical, Inc. (“Envoy Medical”) ( NASDAQ: COCH ), a hearing health company, today is providing a business update and its financial results for the quarter ended September 30, 2023.
- Envoy Medical is a medical technology company specializing in revolutionary “fully” or “totally” implanted hearing devices.
- We believe these accomplishments put Envoy Medical on track to advance our strategic plan over the next several years.
- As a newly listed Company on the Nasdaq Stock Exchange, Envoy Medical will host an introductory educational virtual event on December 7.
